Ewing’s sarcoma is a very rare type of childhood bone cancer that affects the mainly children and young adults and is more commonly presented in males rather than females. Sarcomas are a type of malignant growth classified as being specifically developed either in soft tissues or bone tissues of the body. Ewing’s sarcoma was originally discovered by an American pioneer in pathology who estimated that this type of cancer can originate anywhere in the body, oftentimes evolving in the bones or soft tissues of the pelvis, legs, ribs or spinal column.
Ewing’s sarcoma usually affects the large and long bones of the body such as the femur, tibia, and fibula and may be characterized by immense pain, discomfort and swelling of the affected area, as well as loss of appetite followed by fatigue and fever. This disease involves a number of risks since it is characterized by the weakening of the bones and if located on a nerve pathway, may cause tingling sensations that may even lead to paralysis, if not treated early. A full pathological evaluation is recommended when diagnosing this disease because it is so closely related to other similar diseases and should be attended to by proper high resonance imaging studies in order to ensure more accurate diagnosis. Additional tests may include a bone-density exam, a review of metabolic skeletal markers, and even a bone biopsy.
Since Ewing’s sarcomas are known to originate in any of one or more areas of the body, an exact diagnosis is very difficult to achieve. In these cases, most oncologists will combine surgery and chemotherapy as an onset treatment, in order to later avoid a relapse of the disease. In this case, chemotherapy is usually the first choice of treatment for this kind of cancer, followed by radiation therapy. Once a patient finishes the entire course of chemotherapy, he is again tested for any additional tumors left in the body to be surgically removed. A surgeon specializing in bone cancers is critical for this kind of operation. Fortunately, due to today’s advanced imaging equipment, reconstructive operative techniques and chemotherapy advances, people are in less of a risk of undergoing amputation and have a higher survival rate and better chance for remission than in former medical techniques in treating this rare disease.